NXTCL fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
NextCell Pharma AB engages in the development of stem cell products. It specializes in the treatment of diabetes and immunosuppression in kidney transplants. The company was founded by Mathias Svahn, Edvard Smith, Hans-Peter Torsten Ekre, and Lena Degling Wilkingsson on March 19, 2014 and is headquartered in Huddinge, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
NXTCL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company